SEQUENT SCIENTIFIC
Back to Balance Sheet
|
SEQUENT SCIENTIFIC Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹263 Cr | ₹173 Cr | ₹176 Cr | ₹209 Cr | ₹154 Cr |
What is the latest Total Non-Current Liabilities ratio of SEQUENT SCIENTIFIC ?
Year | Total Non-Current Liabilities |
---|---|
Mar2025 | ₹263 Cr |
Mar2024 | ₹173 Cr |
Mar2023 | ₹176 Cr |
Mar2022 | ₹209 Cr |
Mar2021 | ₹154 Cr |
How is Total Non-Current Liabilities of SEQUENT SCIENTIFIC Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹263 Cr | 52.53 | |
Mar2024 | ₹173 Cr | -1.85 | |
Mar2023 | ₹176 Cr | -15.92 | |
Mar2022 | ₹209 Cr | 36.16 | |
Mar2021 | ₹154 Cr | - |
Compare Total Non-Current Liabilities of peers of SEQUENT SCIENTIFIC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SEQUENT SCIENTIFIC | ₹4,390.3 Cr | 4.3% | -6.3% | 24.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹394,115.0 Cr | 3.5% | -3.4% | -5.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,735.0 Cr | 3.7% | -10.2% | 25.6% | Stock Analytics | |
CIPLA | ₹126,313.0 Cr | 5.3% | 6.1% | -1.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,592.0 Cr | 1.4% | 4.6% | 7.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,095.0 Cr | 3.9% | 0% | -9.9% | Stock Analytics |
SEQUENT SCIENTIFIC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SEQUENT SCIENTIFIC | 4.3% |
-6.3% |
24.9% |
SENSEX | -0% |
-2.4% |
1.2% |
You may also like the below Video Courses